CV Sciences, Inc. (CVSI) Form 8-K Material Events
CV Sciences, Inc. (CVSI) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CVSI
CIK: 1510964
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Haskell & White LLP
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerDavid Brownstein
Audit LocationIrvine, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-09 | 2026-07-16 | PRIMARY DOCUMENT | 0001202557-26-000005 | View SEC Doc Filr Page |
| 3 | 2026-09-09 | 2026-07-09 | PRIMARY DOCUMENT | 0001202557-26-000004 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-09 | — | SCHEDULE 13G Filing | 0001202557-26-000003 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-349211 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-05-14 | 8-K | 0001193125-26-349136 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2025-03-27 | 8-K | 0001193125-26-257417 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001193125-26-226702 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001193125-26-223967 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-15 | 2026-04-15 | DEF 14A | 0001193125-26-155621 | View SEC Doc Filr Page |
| 8-K | 2026-04-10 | 2026-04-06 | 8-K | 0001193125-26-151228 | View SEC Doc Filr Page |
| 10-K | 2026-03-26 | 2025-12-31 | 10-K | 0001193125-26-126598 | View SEC Doc Filr Page |
| 8-K | 2026-03-26 | 2026-03-26 | 8-K | 0001193125-26-126211 | View SEC Doc Filr Page |
| 8-K | 2026-03-10 | 2025-10-07 | 8-K | 0001193125-26-100436 | View SEC Doc Filr Page |
| 10-Q | 2025-11-13 | 2025-09-30 | 10-Q | 0001193125-25-280515 | View SEC Doc Filr Page |
| 8-K | 2025-11-13 | 2025-11-13 | 8-K | 0001193125-25-280116 | View SEC Doc Filr Page |
| 8-K | 2025-10-10 | 2025-10-07 | 8-K | 0001193125-25-237188 | View SEC Doc Filr Page |
| 8-K | 2025-09-18 | 2025-02-12 | 8-K | 0001193125-25-207436 | View SEC Doc Filr Page |
| 10-Q | 2025-08-13 | 2025-06-30 | 10-Q | 0000950170-25-108171 | View SEC Doc Filr Page |
| 8-K | 2025-08-13 | 2025-03-27 | 8-K | 0000950170-25-107984 | View SEC Doc Filr Page |
| 8-K | 2025-06-05 | 2025-03-27 | 8-K | 0000950170-25-081934 | View SEC Doc Filr Page |
| 10-Q | 2025-05-14 | 2025-03-31 | 10-Q | 0000950170-25-071559 | View SEC Doc Filr Page |
| 8-K | 2025-05-14 | 2025-03-27 | 8-K | 0000950170-25-071347 | View SEC Doc Filr Page |
| DEF 14A | 2025-04-15 | 2025-04-15 | DEF 14A | 0000950170-25-054326 | View SEC Doc Filr Page |
| 10-K | 2025-03-27 | 2024-12-31 | 10-K | 0000950170-25-046180 | View SEC Doc Filr Page |
| 8-K | 2025-03-27 | 2025-03-27 | 8-K | 0000950170-25-045761 | View SEC Doc Filr Page |